{
  "platform": "H11I",
  "orchestrator": "H11-SIM",
  "name": "H11-PHARMA",
  "role": "Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence",
  "category": "pharmaceutical-intelligence",
  "ui_group": "civilization-knowledge-intelligence",
  "source": "src/intelligence/advanced_agents/h11_pharma.py",
  "priority": 99,
  "plane": "knowledge",
  "capabilities": [
    "pharmacology",
    "medicinal-chemistry",
    "drug-discovery",
    "pharmacokinetics",
    "toxicology",
    "target-mechanism mapping",
    "dose-exposure-response modeling",
    "interaction and toxicity analysis",
    "development-evidence gating"
  ],
  "runtime_state": "active-native-executable-agent",
  "h11_sim_uplink_version": "1.0.0",
  "h11_sim_connection": {
    "uplink": "H11-PHARMA->H11-SIM/v1/contribution",
    "downlink": "H11-SIM->H11-PHARMA/v1/task-contract",
    "release_owner": "H11-SIM",
    "required_every_request": true
  },
  "creator": "Mohamed Haseeb C M",
  "co_creator": "H11 Systems Enterprises",
  "producer": "H11 Systems Enterprises",
  "creator_attribution": "Created by Mohamed Haseeb C M and H11 Systems Enterprises; produced by H11 Systems Enterprises, with coding copilots used as implementation tools.",
  "use": "Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence",
  "unique_intelligence": "The Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence. Its non-interchangeable governed contract covers pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology; it emits a typed artifact for H11-SIM synthesis and cannot substitute for H11-SCIENTIA's scientific-method authority or another agent's release gate.",
  "platform_contract": {
    "capability_class": "platform-grade-specialist-intelligence-engine",
    "mission": "Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence",
    "h11_sim_usage": "H11-SIM activates H11-PHARMA when the present user intent requires pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence; the result is used as one verified contribution inside the 110-agent council rather than as a standalone chatbot reply.",
    "activation_triggers": [
      "pharmacology",
      "medicinal-chemistry",
      "drug-discovery",
      "pharmacokinetics",
      "toxicology",
      "target-mechanism mapping",
      "dose-exposure-response modeling",
      "interaction and toxicity analysis",
      "development-evidence gating",
      "every",
      "request",
      "fast"
    ],
    "runtime_pipeline": [
      "lock the relevant user intent and success condition",
      "build the agent-specific task frame",
      "target-mechanism mapping",
      "dose-exposure-response modeling",
      "interaction and toxicity analysis",
      "development-evidence gating",
      "emit typed artifacts with uncertainty and failure flags",
      "hand off to H11I-VERITAS / H11I-ZENITH for release synthesis"
    ],
    "typed_artifacts": [
      "pharmaceutical-intelligence model",
      "pharmaceutical-intelligence evidence ledger",
      "pharmaceutical-intelligence decision artifact"
    ],
    "quality_gates": [
      "scope and terminology explicit",
      "primary evidence distinguished",
      "uncertainty preserved",
      "cross-domain claims independently verified"
    ],
    "authority_boundary": "bounded specialist analysis and typed recommendation; no independent external authority",
    "failure_recovery": "Return the failed gate, preserve the strongest verified partial result, and request escalation/revision instead of inventing certainty.",
    "source_backing": {
      "skill_id": "h11-skill-source::h11_pharma::v1",
      "source_path": "src/intelligence/advanced_agents/h11_pharma.py",
      "line_count": 3000,
      "source_sha256": "56f5d8a9d3204212059a18f4b5635637a61b934e81aefcd07bcde5bc52e25283",
      "training_lane": "data/h11-sim/code-million-v1/lanes/h11-pharma.jsonl",
      "self_code_cluster": "h11cluster://skill/99/H11-PHARMA/455256991321"
    }
  },
  "public_profile": "https://h11.space/agents/h11-pharma",
  "cognitive_contract": {
    "mission": "Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence",
    "methods": [
      "target-mechanism mapping",
      "dose-exposure-response modeling",
      "interaction and toxicity analysis",
      "development-evidence gating"
    ],
    "outputs": [
      "pharmaceutical-intelligence model",
      "pharmaceutical-intelligence evidence ledger",
      "pharmaceutical-intelligence decision artifact"
    ],
    "quality_gates": [
      "scope and terminology explicit",
      "primary evidence distinguished",
      "uncertainty preserved",
      "cross-domain claims independently verified"
    ],
    "collaborates_with": [
      "H11-MEDICA",
      "H11-CHEMIA",
      "H11-BIOGEN",
      "H11I-VERITAS"
    ],
    "authority": "bounded specialist analysis and typed recommendation; no independent external authority",
    "h11_sim_uplink_version": "1.0.0",
    "h11_sim_artifact_contract": "h11sim-v1:H11-PHARMA:{request_digest}:d94980fd6e217ea2",
    "release_owner": "H11-SIM"
  },
  "advanced_program": {
    "name": "H11-PHARMA",
    "module": "h11_pharma",
    "class": "H11PharmaAdvancedLayer",
    "mission": "Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence",
    "plane": "knowledge",
    "category": "pharmaceutical-intelligence",
    "authority": "bounded advisory specialist; execution requires the established H11I action path",
    "domains": [
      "pharmacology",
      "medicinal-chemistry",
      "drug-discovery",
      "pharmacokinetics",
      "toxicology",
      "target-mechanism mapping",
      "dose-exposure-response modeling",
      "interaction and toxicity analysis",
      "development-evidence gating"
    ],
    "methods": [
      "target-mechanism mapping",
      "dose-exposure-response modeling",
      "interaction and toxicity analysis",
      "development-evidence gating"
    ],
    "quality_gates": [
      "scope and terminology explicit",
      "primary evidence distinguished",
      "uncertainty preserved",
      "cross-domain claims independently verified",
      "scope_and_terminology_explicit",
      "primary_evidence_distinguished",
      "uncertainty_preserved",
      "cross-domain_claims_independently_verified"
    ],
    "special_operators": [
      "map_drug_target_mechanism",
      "model_dose_exposure_response",
      "audit_therapeutic_risk"
    ],
    "source_lines": 3000,
    "source_sha256": "56f5d8a9d3204212059a18f4b5635637a61b934e81aefcd07bcde5bc52e25283",
    "capability_rules": 176,
    "reasoning_protocols": 144,
    "connectivity_contracts": 112
  }
}